Cost-effectiveness of ivosidenib in patients with previously treated isocitrate dehydrogenase 1 (IDH1)-mutant cholangiocarcinoma: An Italian perspective

Hepatobiliary & pancreatic diseases international 2026

View at publisher

Authors: Jacopo Giuliani, Emilia Durante, Marco Muraro, Silvia Katlauskas Muraro, Marina Tommasi, Francesco Fiorica, Teodoro Sava

DOI: 10.1016/j.hbpd.2025.12.018

Cited by: 1

References: 12

Fields of Study & Subjects

Cholangiocarcinoma and Gallbladder Cancer Studies Gastric Cancer Management and Outcomes Lung Cancer Treatments and Mutations

References 12